Publications

Journal Article Review Epublish 4 citations

PubMed: 39000157 DOI: 10.3390/ijms25137042

The Role of the Nrf2 Pathway in Airway Tissue Damage Due to Viral Respiratory Infections.

Int J Mol Sci 25(13)

Authors: Arnaud John Kombe Kombe, Leila Fotoohabadi, Ravikanth Nanduri, Yulia Gerasimova, Maria Daskou, Chandrima Gain, Eashan Sharma, Michael Wong, Theodoros Kelesidis

Affiliations

  • Division of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.

Abstract

Respiratory viruses constitute a significant cause of illness and death worldwide. Respiratory virus-associated injuries include oxidative stress, ferroptosis, inflammation, pyroptosis, apoptosis, fibrosis, autoimmunity, and vascular injury. Several studies have demonstrated the involvement of the nuclear factor erythroid 2-related factor 2 (Nrf2) in the pathophysiology of viral infection and associated complications. It has thus emerged as a pivotal player in cellular defense mechanisms against such damage. Here, we discuss the impact of Nrf2 activation on airway injuries induced by respiratory viruses, including viruses, coronaviruses, rhinoviruses, and respiratory syncytial viruses. The inhibition or deregulation of Nrf2 pathway activation induces airway tissue damage in the presence of viral respiratory infections. In contrast, Nrf2 pathway activation demonstrates protection against tissue and organ injuries. Clinical trials involving Nrf2 agonists are needed to define the effect of Nrf2 therapeutics on airway tissues and organs damaged by viral respiratory infections.

MeSH

Fibrosis, Lung Injury, Respiratory Tract Infections, Ferroptosis, Oxidative Stress, Viruses, Pyroptosis, Apoptosis, Tissues, Wounds And Injuries, Infections, Autoimmunity

Cited by